phase 1_completion
saveFortrea Holdings Inc — balinatunfib (Phase I Trial Completion)
community read0 votes
Therapy area: Gastrointestinal, Immunology. Indication: Crohn's Disease (Regional Enteritis), Inflammatory Bowel Disease, Plaque Psoriasis (Psoriasis Vulgaris), Rheumatoid Arthritis, Ulcerative Colitis
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that